Non-small cell lung carcinoma (NSCLC) -192, 200b, 194, 424, 98 and 212) exhibited more than 2-fold changes in their expression levels, which were validated by qRT-PCR. The expression of three miRNAs (miR-200b, 194 and 212) (miR-192, 424 and 98) 
protein (survivin), alteration in tubulin dynamics and differences in ␤-tubulin isotype expression [4] [5] [6] [7] [8] [9] . However, the mechanism of docetaxel resistance is very complicated and still unclear, so it needs to be further elucidated.
The changes of chemoresistant gene expression include DNA, mRNA and protein levels, but the levels of mRNA and the encoded proteins are often not proportional, which can have a number of causes, among them, post-transcriptional regulation by microRNAs (miRNAs) . miRNAs are small non-coding RNAs of 21 to 25 nucleotides that negatively modulate protein expression [10] . miRNAs are involved in several biological processes, such as development, proliferation, apoptosis and differentiation [11, 12] . Moreover, many studies have shown that aberrant microRNA expression is correlated with malignant transformation and tumour development [13, 14] . Thus, 
we demonstrated that miRNAs might play important roles in mediating chemosensitivity and resistance of human tumours. In order to identify miRNAs and determine their roles in mediating docetaxel resistance in NSCLC, we employed a microRNA array to detect a distinctive miRNA expression pattern of docetaxel-resistant NSCLC cell line (SPC-A1/docetaxel) different from that of docetaxel-sensitive NSCLC cell line (SPC-A1). Then, we employed bioinformatics methods for the analysis of miRNA expression arrays to find the target genes regulated by miRNAs, and further analyse their functions associated with chemoresistance of tumours. The expression of a few target genes were chosen to be confirmed by quantitative real-time RT-PCR (qRT-PCR) and Western blot assays. Taken together, the miRNA signature of docetaxel resistance could be helpful to develop novel strategies for targeted therapies in chemorefractive NSCLC patients.

Materials and methods
Cell lines and cell culture
Results
Main experimental procedure
In the present study, experiments and bioinformatics methods were integrated to create a global view of specific miRNAs associated with docetaxel resistance of NSCLC, thus allowing their targets and functions to be identified (Fig. 1) . (Fig. 3) (Fig. 4) [15, 16] 
Analysis of the quality of RNA isolated from SPC-Al and SPC-A1/docetaxel cells
do). By analysis of above three databases, human genes which were known to be involved in cell proliferation, apoptosis, cell cycle and DNA
Fig. 3 Microarray chip analysis of miRNAs expression in both docetaxel-resistant NSCLC cell line (SPC-A1/docetaxel) and control NSCLC cell line (SPC-A1
Confirmation of the expression of a few target genes by qRT-PCR and Western blot assays qRT-PCR or Western blot assays were performed to detect the expression of a few potential target genes (ABCC3, Bcl-2, BIK, PRKCA, Aurora-A and ERBB2IP) at both transcriptional and translational levels. As shown in Fig. 5, the mRNA and protein expression levels of ABCC3 and BIK genes in SPC-A1/docetaxel cells were significantly lower than those in SPC-A1 cells (P Ͻ 0.05), while the mRNA and protein expression levels of Bcl-2, PRKCA and Aurora-A genes in SPC-A1 cells were significantly higher than those in SPC-A1 cells (P Ͻ 0.05). Although the mRNA expression level of ERBB2IP gene showed no difference between SPC-A1/docetaxel cell and SPC-A1 cell (P Ͼ 0.05), the protein expression level of ERBB2IP gene in SPC-A1/docetaxel cell was significantly higher than that in SPC-A1 cell. Therefore, the expression levels of miRNAs showed inverse correlation with the protein expression levels of their potential target genes. MiRNAs inhibit target gene expression, by interacting with target mRNAs at specific sites in order to induce cleavage of the message RNA or inhibit translation, therefore, the regulation of potential target genes by miRNAs might take place at pre-translation or translation stage, which finally induces the inhibition of protein expression.
Discussion
Non-small-cell lung cancer (NSCLC) is a major global health problem. Despite improvement in diagnosis and treatment, over 60,0000 patients still die of lung cancer annually in China. Current treatment options for patients with NSCLC depend on the stage of disease and mainly include surgery, chemotherapy, radiation therapy, immunotherapy and targeted therapies
Concluding remarks
Taken together, our experimental data showed that alteration of miRNA expression profile in docetaxel-resistant NSCLC cell line might deregulate drug resistance-related genes and would provide potential mechanisms that underlie in the docetaxel resistance of NSCLC and provide a novel molecular therapeutic target for chemorefractive NSCLC therapy.
